- J&J is seeking a court order blocking copies until the patent has expired, and cash compensation if copies are made before then, according to
complaintfiled Wednesday in federal court in Trenton, New Jersey
- Trinza is a quarterly injectable of Invega Sustenna, which is dosed monthly
- Patent expires in April 2036: FDA Orange Book
- Invega Sustenna and Trinza had U.S. sales of $1.12 billion during the first half of 2020, up by 13.2% from the same period in ...
Sept. 25, 2020, 10:10 PM